Publication | Open Access
The Toll-Like Receptor 4-Antagonist Eritoran Reduces Murine Cardiac Hypertrophy
72
Citations
30
References
2011
Year
Application of the TLR4 antagonist eritoran attenuates the development of cardiac hypertrophy possibly by a reduction in inflammatory and increase in anti-inflammatory cytokines.
| Year | Citations | |
|---|---|---|
Page 1
Page 1